145 related articles for article (PubMed ID: 22790561)
21. Regioselective synthesis and antitumor screening of some novel N-phenylpyrazole derivatives.
Farag AM; Mayhoub AS; Barakat SE; Bayomi AH
Bioorg Med Chem; 2008 Jan; 16(2):881-9. PubMed ID: 17962022
[TBL] [Abstract][Full Text] [Related]
22. Utilization of Cyanoacetohydrazide and Oxadiazolyl Acetonitrile in the Synthesis of Some New Cytotoxic Heterocyclic Compounds.
Shaker SA; Marzouk MI
Molecules; 2016 Jan; 21(2):155. PubMed ID: 26840279
[TBL] [Abstract][Full Text] [Related]
23. Synthesis of 1-substituted 3-aryl-5-aryl(hetaryl)-2-pyrazolines and study of their antitumor activity.
Insuasty B; Chamizo L; Muñoz J; Tigreros A; Quiroga J; Abonía R; Nogueras M; Cobo J
Arch Pharm (Weinheim); 2012 Apr; 345(4):275-86. PubMed ID: 22105771
[TBL] [Abstract][Full Text] [Related]
24. Design, synthesis, cytotoxicity, HuTopoIIα inhibitory activity and molecular docking studies of pyrazole derivatives as potential anticancer agents.
Alam R; Wahi D; Singh R; Sinha D; Tandon V; Grover A; Rahisuddin
Bioorg Chem; 2016 Dec; 69():77-90. PubMed ID: 27744115
[TBL] [Abstract][Full Text] [Related]
25. Use of 2-aminoprop-1-ene-1,1,3-tricarbonitrile for the synthesis of tetrahydronaphthalene, hexahydroisoquinoline and hexahydrocinnoline derivatives with potential antitumor activities.
Mohareb RM; Moustafa HE
Acta Pharm; 2011 Mar; 61(1):51-62. PubMed ID: 21406343
[TBL] [Abstract][Full Text] [Related]
26. Synthesis of novel pyrazolic analogues of chalcones and their 3-aryl-4-(3-aryl-4,5-dihydro-1H-pyrazol-5-yl)-1-phenyl-1H-pyrazole derivatives as potential antitumor agents.
Insuasty B; Tigreros A; Orozco F; Quiroga J; Abonía R; Nogueras M; Sanchez A; Cobo J
Bioorg Med Chem; 2010 Jul; 18(14):4965-74. PubMed ID: 20594863
[TBL] [Abstract][Full Text] [Related]
27. Synthesis of novel analogs of 2-pyrazoline obtained from [(7-chloroquinolin-4-yl)amino]chalcones and hydrazine as potential antitumor and antimalarial agents.
Insuasty B; Montoya A; Becerra D; Quiroga J; Abonia R; Robledo S; Vélez ID; Upegui Y; Nogueras M; Cobo J
Eur J Med Chem; 2013 Sep; 67():252-62. PubMed ID: 23871905
[TBL] [Abstract][Full Text] [Related]
28. New approaches for the synthesis of thiophene derivatives with anti-tumor activities.
Mohareb RM; Abbas NS; Ibrahim RA
Acta Chim Slov; 2013; 60(3):583-94. PubMed ID: 24169713
[TBL] [Abstract][Full Text] [Related]
29. Novel polyazaheterocyclic systems: Synthesis, antitumor, and antimicrobial activities.
Riyadh SM; Farghaly TA; Gomha SM
Arch Pharm Res; 2010 Nov; 33(11):1721-8. PubMed ID: 21116773
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and Anticancer Evaluations of Novel Thiazole Derivatives Derived from 4-Phenylthiazol-2-amine.
Abdallah AEM; Mohareb RM; Helal MHE; Mofeed GJ
Acta Chim Slov; 2021 Sep; 68(3):604-616. PubMed ID: 34897524
[TBL] [Abstract][Full Text] [Related]
31. Synthesis, characterization and in-vitro antiproliferative effects of novel 5-amino pyrazole derivatives against breast cancer cell lines.
Raju H; Chandrappa S; Prasanna DS; Ananda H; Nagamani TS; Byregowda SM; Rangappa KS
Recent Pat Anticancer Drug Discov; 2011 May; 6(2):186-95. PubMed ID: 21247401
[TBL] [Abstract][Full Text] [Related]
32. New Approaches for the Synthesis, Cytotoxicity and Toxicity of Heterocyclic Compounds Derived from 2-Cyanomethylbenzo[c]imidazole.
Mohareb RM; Mohamed AA; Abdallah AE
Acta Chim Slov; 2016; 63(2):227-40. PubMed ID: 27333544
[TBL] [Abstract][Full Text] [Related]
33. Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents.
Dawood KM; Eldebss TM; El-Zahabi HS; Yousef MH; Metz P
Eur J Med Chem; 2013; 70():740-9. PubMed ID: 24231309
[TBL] [Abstract][Full Text] [Related]
34. Synthesis, antitumor activity and molecular docking study of novel benzofuran-2-yl pyrazole pyrimidine derivatives.
El-Zahar MI; Adb El-Karim SS; Haiba ME; Khedr MA
Acta Pol Pharm; 2011; 68(3):357-73. PubMed ID: 21648190
[TBL] [Abstract][Full Text] [Related]
35. 3-methyl-2-(4-substituted phenyl)-4,5-dihydronaphtho[1,2-c]-pyrazoles: synthesis and in-vitro biological evaluation as antitumour agents.
Al-Saadi MS; Rostom SA; Faidallah HM
Arch Pharm (Weinheim); 2008 Mar; 341(3):181-90. PubMed ID: 18214843
[TBL] [Abstract][Full Text] [Related]
36. Synthesis and anticancer activity of new class of bisphosphonates/phosphanamidates.
Kiran YB; Devendranath Reddy C; Gunasekar D; Suresh Reddy C; Leon A; Barbosa LC
Eur J Med Chem; 2008 Apr; 43(4):885-92. PubMed ID: 17640773
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and in vitro antitumor activity of new 4,5-dihydropyrazole derivatives.
Congiu C; Onnis V; Vesci L; Castorina M; Pisano C
Bioorg Med Chem; 2010 Sep; 18(17):6238-48. PubMed ID: 20702096
[TBL] [Abstract][Full Text] [Related]
38. Fluoroalkane thioheterocyclic derivatives and their antitumor activity.
Li G; Sun Q; Wang D; Xu Y; Zhuang J; Zhang Q; Sun D
Eur J Med Chem; 2015 Mar; 93():423-30. PubMed ID: 25728023
[TBL] [Abstract][Full Text] [Related]
39. Biological Validation of Novel Polysubstituted Pyrazole Candidates with in Vitro Anticancer Activities.
Fahmy HH; Khalifa NM; Ismail MM; El-Sahrawy HM; Nossier ES
Molecules; 2016 Feb; 21(3):271. PubMed ID: 26927048
[TBL] [Abstract][Full Text] [Related]
40. Polysubstituted pyrazoles, part 5. Synthesis of new 1-(4-chlorophenyl)-4-hydroxy-1H-pyrazole-3-carboxylic acid hydrazide analogs and some derived ring systems. A novel class of potential antitumor and anti-HCV agents.
Rostom SA; Shalaby MA; El-Demellawy MA
Eur J Med Chem; 2003; 38(11-12):959-74. PubMed ID: 14642328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
